Johnson & Johnson is offering attendees of the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting this weekend a sneak peek of its latest IOL: the TECNIS Odyssey, a new presbyopia-correcting (PC) intraocular lens (IOL).
Let’s start with J&J’s IOLs.
The multinational pharmaceutical and medical company’s product lineup of TECNIS-branded IOLs and implants is already advanced, extensive, and robust.
Its featured IOLs include both monofocal and PC lenses such as:
- TECNIS Symfony OptiBlue IOL
- Presbyopia-correcting
- TECNIS Synergy IOL with TECNIS SIMPLICITY Delivery System
- Presbyopia-correcting
- TECINS Eyhance IOL with TECNIS SIMPLICITY Delivery System
- Monofocal
Now focusing more on these PC lenses …
The company offers six lenses in this category, including (aside from those two featured IOLs):
- TECNIS Symfony OptiBlue Toric II IOL
- TECNIS Synergy Toric II IOL with TECNIS SIMPLICITY Delivery System
- TECNIS Multifocal IOL +2.75D
- TECNIS Multifocal Toric II IOL+3.25D
Now this latest IOL.
Designed to provide full visual range—near and distance vision—the TECNIS Odyssey is a premium IOL intended to provide reduced night vision symptoms as well as top-quality contrast and low-light performance.
Its design: The lens is made of acrylic and uses J&J’s TECNIS Synergy technology to blend light rays and allow for them to focus on the eye’s back surface—a stark contrast to conventional monofocal IOLs, which only focuses light from objects at a distance.
Explain TECNIS Synergy more.
This technology was originally launched in 2019 with the TECNIS Synergy IOL, which allowed for patients to have continuous high-contrast vision for both near and far vision—even in low-light conditions.
Gotcha. So any clinical data on this lens yet?
That brings us to ASCRS’s annual meeting! J&J is presenting key data from five investigator-led, real-world outcome studies on the TECNIS Odyssey (more on those later).
The company noted that the data suggested the TECNIS Odyssey provides “full visual range from distance to near vision with minimal visual complaints and a high rate of being spectacle-free.”
Further, the findings “demonstrate that the newest PC-IOL provides … high image quality and tolerance to residual refractive error as compared to existing multifocal and hybrid presbyopia correcting IOLs,” according to J&J.
And these ASCRS presentations?
These data presentations include (but are not limited to):
- Introduction of a Next Generation Presbyopia Correcting IOL
Presented by: William L. Soscia, MD
When: Friday, April 5, 8:10 – 8:20 pm EST
Location: BCEC. (Abstract #50695) - Introduction of a Next Generation Presbyopia Correcting IOL.
Presented by: William L. Soscia, MD
When: Friday, April 5, 8:10 – 8:20 pm EST
Location: BCEC. (Abstract #50695) - Tolerance to Refractive Error of a Next Generation Presbyopia Correcting IOL.
Presented by: Zaina Al-Mohtaseb, MD
When: Saturday, April 6, 4:15 – 4:20 pm EST
Location: BCEC – Meeting Level 2, Room 256. (Abstract #50696) - Clinical Evaluation of Tolerance to Residual Refractive Errors Following Implantation with New Diffractive Presbyopia Correcting IOL
Presented by: David Chang, MD
When: Saturday, April 6, 11:05 – 11:10 am EST
Location: BCEC – Meeting Level 2, Room 295B. (Abstract #50694) - Depth of Focus and Spectacle Independence 1-Month Outcomes for a New Full-Range Spectacle Independence IOL
Presented by: George Waring, IV, MD
When: Saturday, April 6, 2024, 10:40 – 10:45 am PST
Location: BCEC – Meeting Level 2, Room 256. (Abstract #50686) - Real World Evidence Visual Outcomes of a New Full-Range Spectacle-Independence Intraocular Lens
Presented by: Priya M. Mathews, MD
When: Saturday, April 6, 11:15 – 11:20 am EST
Location: BCEC – Meeting Level 2, Room 295B. (Abstract #50685)
See here for more details and to register for the sessions.
How about real-world data?
For additional study data, click here to watch an interview with William (Bill) L. Soscia, MD, an investigator from a real-world study (NCT05991960) on the TECNIS Odyssey in which the first 100 eyes were implanted with the IOL. In his words, the results were “outstanding” and patients’ eyes presented with “continuous range of vision, from distance, intermediate, and near.”
Nice! So when might this lens be available?
According to J&J, the TECNIS Odyssey is expected to have a “full market release later this year.”
And if you’re attending the ASCRS meeting, stop by the company’s booth #2380 for more info!
The ASCRS / American Society of Ophthalmic Administrators (ASOA) annual meeting is being held April 5-8, 2024, in Boston, Massachusetts.